We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+31.18%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$553M
AUM Growth
+$115M
Cap. Flow
-$3.28M
Cap. Flow %
-0.59%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$3.28M

Sector Composition

Rank Sector Weight
1 Healthcare 97.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABMD
1
DELISTED
Abiomed Inc
ABMD
$208M 37.57%
1,450,000
– –
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$121M 21.92%
4,592,047
– –
AXGN icon
3
Axogen
AXGN
$2.5B
$81.4M 14.72%
4,861,111
– –
CORI
4
DELISTED
Corium International, Inc.
CORI
$69.8M 12.62%
9,353,304
– –
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$53.5M 9.68%
3,231,656
– –
ELGX
6
DELISTED
Endologix Inc
ELGX
$11.7M 2.12%
125,747
– –
MNOV icon
7
MediciNova
MNOV
$66M
$6.16M 1.11%
1,170,370
– –
ACUR
8
DELISTED
Acura Pharmaceuticals
ACUR
$1.1M 0.2%
1,956,397
– –
GYRE icon
9
Gyre Therapeutics
GYRE
$744M
$372K 0.07%
10,483
– –
LGND icon
10
Ligand Pharmaceuticals
LGND
$6.36B
– –
-49,687
Closed -$3.28M

Similar funds

1W
1776 Wealth Atlanta, Georgia $254M AUM 20.38% 1-Year Est. Return
TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
LI
LHM Inc Sandy, Utah $254M AUM 13.16% 1-Year Est. Return
LIA
LifePlan Investment Advisors Raleigh, North Carolina $254M AUM 17.26% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return

Essex Woodlands Management's Q2 2017 Portfolio in Review

As of Q2 2017, Essex Woodlands Management held 10 positions worth $553M, up 26% from $438M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management's Q2 2017 filing shows 1 closed position. The largest sale was Ligand Pharmaceuticals, an estimated $3.28M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier.

  • Essex Woodlands Management fully exited Ligand Pharmaceuticals in Q2 2017, selling an estimated $3.28M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $553M portfolio in Q2 2017.
  • Essex Woodlands Management opened 0 new positions and closed 1 in Q2 2017.
  • Essex Woodlands Management's portfolio value rose 26% quarter-over-quarter to $553M.

Based on Essex Woodlands Management's 13F filing for Q2 2017, filed 14 Aug 2017.